Trial Profile

Randomized, Placebo-Controlled, Double-Masked Study of the Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Phentolamine (Primary)
Indications Ocular hypertension; Open-angle glaucoma; Presbyopia
Focus Therapeutic Use
Acronyms ORION-1
Sponsors Ocuphire Pharma

Most Recent Events

20 Jan 2021 According to an Ocuphire Pharma media release, highlights from this study were presented by Dr. Jay Pepose at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2020.
20 Jan 2021 Results published in the Ocuphire Pharma Media Release.
20 Jan 2021 According to an Ocuphire Pharma media release, results from this study have been published in Clinical Ophthalmology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com